Clinical evaluation of GP-41299). An anti-anxiety agent of the doxepine type.
D000328:Adult; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D003988:Dibenzothiepins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003990:Dibenzoxepins / Q000494:pharmacology; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D014149:Tranquilizing Agents / Q000494:pharmacology / Q000627:therapeutic use
D000928:Antidepressive Agents; D003988:Dibenzothiepins; D003990:Dibenzoxepins; D010919:Placebos; D014149:Tranquilizing Agents